Grants and Funding
NIH Human Embryonic Stem Cell Registry
Submitted hESC Lines Pending Review

The following is a list of human embryonic stem cell lines submitted to NIH, which are PENDING review to determine if they may be used in NIH funded research.

Pending Lines: 
Sorted by:
Date/Time:
32  (in 16 Submissions)
Cell Line Name
08/27/2014 at 08:20 PM
Cell Line Name Ascending Sort Organization Date Submitted
CSC14 California Stem Cell, Inc. 11/09/2012
MA 09 Advanced Cell Technology, Inc. * 12/30/2009
MA 42 Advanced Cell Technology, Inc. 02/04/2010
MA 50 Advanced Cell Technology, Inc. 02/04/2010
NED 1 Advanced Cell Technology, Inc. * 12/24/2009
NED 2 Advanced Cell Technology, Inc. * 12/24/2009
NED 3 Advanced Cell Technology, Inc. * 12/24/2009
NED 4 Advanced Cell Technology, Inc. * 12/24/2009
UCLA 13 University of California, Los Angeles 06/18/2014
UCLA 14 University of California, Los Angeles 06/18/2014
UCLA 15 University of California, Los Angeles 06/18/2014
UCLA 16 University of California, Los Angeles 06/18/2014
UCLA 17 University of California, Los Angeles 06/18/2014
UCLA 18 University of California, Los Angeles 06/18/2014
UCSFB1 University of California San Francisco * 12/04/2009
UCSFB10 University of California San Francisco * 12/04/2009
UCSFB2 University of California San Francisco * 12/04/2009
UCSFB3 University of California San Francisco * 12/04/2009
UCSFB4 University of California San Francisco * 12/04/2009
UCSFB5 University of California San Francisco * 12/04/2009
UCSFB6 University of California San Francisco * 12/04/2009
UCSFB7 University of California San Francisco * 12/04/2009
UCSFB8 University of California San Francisco * 12/04/2009
UCSFB9 University of California San Francisco * 12/04/2009
UM112-1 PGD; disease-specific mutation University of Michigan 06/04/2014
UM114-10 University of Michigan 06/25/2014
UM121-7 University of Michigan 06/25/2014
UM134-1 PGD; disease-specific mutation University of Michigan 06/04/2014
UM139-2 PGD; disease-specific mutation University of Michigan 06/25/2014
UM76-1 PGS; abnormal karyotype University of Michigan 06/25/2014
UM78-2 University of Michigan 06/04/2014
UM90-12 PGS; abnormal karyotype University of Michigan 06/04/2014

* This cell line is ineligible for review under the NIH Guidelines for Human Stem Cell Research because the line was derived from a pre-blastocyst embryo. The Guidelines define human embryonic stem cells as "cells that are derived from the inner cell mass of blastocyst stage human embryos..." NIH has proposed a change to this definition, and therefore has not deleted this submission from the "Pending Review" list.


Total Pending Lines = 32


Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011
Content Manager: stemcell@mail.nih.gov 
Technical Issues: E-mail OER Webmaster